Affiliation:
1. Pirogov Russian National Research Medical University
Abstract
The prevalence of diabetes mellitus (DM) is growing at an alarming rate worldwide. Diabetic complications are one of the leading causes of disability, morbidity and premature mortality. Along with chronic hyperglycemia, persistent systemic inflammation on the background of insulin resistance, dyslipidemia plays an important role in the development of macrovascular complications of diabetes. DM is characterized by the development of a mixed form of dyslipidemia, characterized by excessive accumulation of the most atherogenic forms of lipids. In most cases, hypertriglyceridemia occurs in type 2 diabetes. The most effective tool for correcting dyslipidemia today is fibrate therapy, including in combination with statins.